612 related articles for article (PubMed ID: 27701420)
21. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
22. JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of Plasmodium.
Birrell GW; Chavchich M; Ager AL; Shieh HM; Heffernan GD; Zhao W; Krasucki PE; Saionz KW; Terpinski J; Schiehser GA; Jacobus LR; Shanks GD; Jacobus DP; Edstein MD
Antimicrob Agents Chemother; 2015 Jan; 59(1):170-7. PubMed ID: 25331702
[TBL] [Abstract][Full Text] [Related]
23. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
Barnes KI; White NJ
Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
[TBL] [Abstract][Full Text] [Related]
24. Maduramicin Rapidly Eliminates Malaria Parasites and Potentiates the Gametocytocidal Activity of the Pyrazoleamide PA21A050.
Maron MI; Magle CT; Czesny B; Turturice BA; Huang R; Zheng W; Vaidya AB; Williamson KC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1492-9. PubMed ID: 26711768
[TBL] [Abstract][Full Text] [Related]
25. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
Delves M; Plouffe D; Scheurer C; Meister S; Wittlin S; Winzeler EA; Sinden RE; Leroy D
PLoS Med; 2012 Feb; 9(2):e1001169. PubMed ID: 22363211
[TBL] [Abstract][Full Text] [Related]
26. Blood-stage antiplasmodial activity and oocyst formation-blockage of metallo copper-cinchonine complex.
Morais CMG; Brito RMM; Weselucha-Birczyńska A; Pereira VSS; Pereira-Silva JW; Menezes A; Pessoa FAC; Kucharska M; Birczyńska-Zych M; Ríos-Velásquez CM; de Andrade-Neto VF
Front Cell Infect Microbiol; 2022; 12():1047269. PubMed ID: 36530433
[TBL] [Abstract][Full Text] [Related]
27. The Nonartemisinin Sesquiterpene Lactones Parthenin and Parthenolide Block Plasmodium falciparum Sexual Stage Transmission.
Balaich JN; Mathias DK; Torto B; Jackson BT; Tao D; Ebrahimi B; Tarimo BB; Cheseto X; Foster WA; Dinglasan RR
Antimicrob Agents Chemother; 2016 Apr; 60(4):2108-17. PubMed ID: 26787692
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of 4-Amino 2-Anilinoquinazolines against
Gilson PR; Nguyen W; Poole WA; Teixeira JE; Thompson JK; Guo K; Stewart RJ; Ashton TD; White KL; Sanz LM; Gamo FJ; Charman SA; Wittlin S; Duffy J; Tonkin CJ; Tham WH; Crabb BS; Cooke BM; Huston CD; Cowman AF; Sleebs BE
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559138
[TBL] [Abstract][Full Text] [Related]
29. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
[TBL] [Abstract][Full Text] [Related]
30. Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.
Trenholme K; Marek L; Duffy S; Pradel G; Fisher G; Hansen FK; Skinner-Adams TS; Butterworth A; Ngwa CJ; Moecking J; Goodman CD; McFadden GI; Sumanadasa SD; Fairlie DP; Avery VM; Kurz T; Andrews KT
Antimicrob Agents Chemother; 2014 Jul; 58(7):3666-78. PubMed ID: 24733477
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects.
Krause A; Dingemanse J; Mathis A; Marquart L; Möhrle JJ; McCarthy JS
Br J Clin Pharmacol; 2016 Aug; 82(2):412-21. PubMed ID: 27062080
[TBL] [Abstract][Full Text] [Related]
32. Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.
Rajendran V; Rohra S; Raza M; Hasan GM; Dutt S; Ghosh PC
Antimicrob Agents Chemother; 2015 Dec; 60(3):1304-18. PubMed ID: 26666937
[TBL] [Abstract][Full Text] [Related]
33. Model system to define pharmacokinetic requirements for antimalarial drug efficacy.
Bakshi RP; Nenortas E; Tripathi AK; Sullivan DJ; Shapiro TA
Sci Transl Med; 2013 Oct; 5(205):205ra135. PubMed ID: 24089407
[TBL] [Abstract][Full Text] [Related]
34. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
[TBL] [Abstract][Full Text] [Related]
35.
Straimer J; Gnädig NF; Stokes BH; Ehrenberger M; Crane AA; Fidock DA
mBio; 2017 Apr; 8(2):. PubMed ID: 28400526
[TBL] [Abstract][Full Text] [Related]
36. Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
Singh S; Rajendran V; He J; Singh AK; Achieng AO; Vandana ; Pant A; Nasamu AS; Pandit M; Singh J; Quadiri A; Gupta N; Poonam ; Ghosh PC; Singh BK; Narayanan L; Kempaiah P; Chandra R; Dunn BM; Pandey KC; Goldberg DE; Singh AP; Rathi B
ACS Infect Dis; 2019 Feb; 5(2):184-198. PubMed ID: 30554511
[TBL] [Abstract][Full Text] [Related]
37. Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria.
Biagini GA; Fisher N; Shone AE; Mubaraki MA; Srivastava A; Hill A; Antoine T; Warman AJ; Davies J; Pidathala C; Amewu RK; Leung SC; Sharma R; Gibbons P; Hong DW; Pacorel B; Lawrenson AS; Charoensutthivarakul S; Taylor L; Berger O; Mbekeani A; Stocks PA; Nixon GL; Chadwick J; Hemingway J; Delves MJ; Sinden RE; Zeeman AM; Kocken CH; Berry NG; O'Neill PM; Ward SA
Proc Natl Acad Sci U S A; 2012 May; 109(21):8298-303. PubMed ID: 22566611
[TBL] [Abstract][Full Text] [Related]
38. MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Penna-Coutinho J; da Silva Araújo M; Campos Aguiar AC; Sá PM; Rios CT; Medeiros JF; Pereira DB; Boechat N; Krettli AU
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():150-155. PubMed ID: 34637981
[TBL] [Abstract][Full Text] [Related]
39. Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity.
Vanaerschot M; Lucantoni L; Li T; Combrinck JM; Ruecker A; Kumar TRS; Rubiano K; Ferreira PE; Siciliano G; Gulati S; Henrich PP; Ng CL; Murithi JM; Corey VC; Duffy S; Lieberman OJ; Veiga MI; Sinden RE; Alano P; Delves MJ; Lee Sim K; Winzeler EA; Egan TJ; Hoffman SL; Avery VM; Fidock DA
Nat Microbiol; 2017 Oct; 2(10):1403-1414. PubMed ID: 28808258
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic Modeling of Primaquine Pharmacokinetics, Gametocytocidal Activity, and Mosquito Infectivity.
Chotsiri P; Mahamar A; Hoglund RM; Koita F; Sanogo K; Diawara H; Dicko A; Simpson JA; Bousema T; White NJ; Brown JM; Gosling R; Chen I; Tarning J
Clin Pharmacol Ther; 2022 Mar; 111(3):676-685. PubMed ID: 34905220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
